Heterozygous activating mutations in CASR cause Autosomal Dominant Hypocalcemia, type 1 (ADH1), or Bartter’s Syndrome, type V (both OMIM# 601198). Here, ADH1A is linked to Bartter syndrome with hypocalcemia.